Medical Journals

Adenoviral Modification of Mouse Brain Derived Endothelial Cells, Bend3, to Induce Apoptosis by Vascular Endothelial Growth Factor.

Authors:
  • Mitsuuchi Y
  • Powell D R
  • Gallo J M

From: Department of Pharmacology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

Oncogene

  • Publish Date: Feb 2006
  • ISSN: 0950-9232
  • Volume: 25
  • Issue: 6
  • Pages: 954-8
  • Medium: Print
  • Language: English
  • Citation (JAMA): Mitsuuchi Y, Powell D R, Gallo J M, et al. Adenoviral Modification of Mouse Brain Derived Endothelial Cells, Bend3, to Induce Apoptosis by Vascular Endothelial Growth Factor.. Oncogene Feb 2006;25:954-8

Abstract

A second generation genetically-engineered cell-based drug delivery system, referred to as apoptotic-induced drug delivery (AIDD), was developed using endothelial cells (ECs) that undergo apoptosis upon binding of vascular endothelial growth factor (VEGF) to a Flk-1:Fas fusion protein (FF). This new AIDD was redesigned using mouse brain derived ECs, bEnd3 cells, and an adenovirus vector in order to enhance and control the expression of FF. The FF was tagged with a HA epitope (FFHA) and designed to be coexpressed with green fluorescence protein (GFP) by the regulation of cytomegalovirus promoters in the adenovirus vector. bEnd3 cells showed favorable coexpression of FFHA and GFP consistent with the multiplicity of infection of the adenovirus. Immunofluorescence analysis demonstrated that FFHA was localized at the plasma membrane, whereas GFP was predominantly located in the cytoplasm of ECs. Cell death was induced by VEGF, but not by platelet derived growth factor or fibroblast growth factor in a dose-dependent manner (range 2-20 ng/ml), and revealed caspase-dependent apoptotic profiles. The FFHA expressing bEnd3 cells underwent apoptosis when cocultured with a glioma cell (SF188V+) line able to overexpress VEGF. The combined data indicated that the FFHA adenovirus system can induce apoptotic signaling in ECs in response to VEGF, and thus, is an instrumental modification to the development of AIDD.

Mesh Headings (Keywords): Adenoviridae, Animals, Antigens, CD95, Apoptosis, Base Sequence, Brain, Cells, Cultured, Central Nervous System Neoplasms, Coculture Techniques, Drug Delivery Systems, Endothelial Cells, Epitopes, Genetic Vectors, Glioma, Humans, Mice, Molecular Sequence Data, Receptors, Tumor Necrosis Factor, Receptors, Vascular Endothelial Growth Factor, Recombinant Fusion Proteins, Vascular Endothelial Growth Factor A


Check for Full Text / PubMed Unique Identifier (PMID): 16247462


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.